MH-062026-IMMUNO-COPIL PUBLICATION - 1

MercurHosp ASBL

Published: Aug 11, 2026

Updated: Aug 11, 2026

Source: belgium_eprocurement

About This Opportunity

This is a supplies contract in the health and medical services and media and communication sectors, with a focus on Publishing. Located in Belgium, Europe, this opportunity is open to firms and consortiums. Proposals must be submitted before September 17, 2026.

Published through Belgium e-Procurement, a national government procurement portal. Public procurement tenders follow the country's national bidding regulations and may have specific eligibility and documentation requirements for the supply of goods in the health and medical services sector. Supply contracts typically require bidders to demonstrate product compliance with technical specifications, delivery capacity, and relevant certifications. Interested parties should review the full documentation on the original source before submitting their proposal.

Description

This tender, MH-062026-IMMUNO-COPIL PUBLICATION - 1, is from Belgium and is listed on the e-procurement platform. The title indicates a procurement related to 'Immunoglobulines IV 10%,' which are intravenous immunoglobulin solutions at a 10% concentration. This procurement is clearly within the healthcare or pharmaceutical sector, likely for hospitals, clinics, or public health services. The contracting authority is seeking a reliable supply of high-quality intravenous immunoglobulin. Typical tender requirements for pharmaceuticals include stringent quality standards (e.g., GMP, pharmacopoeia compliance), proven efficacy and safety profiles, secure supply chain management, appropriate packaging and storage conditions, and timely delivery. Bidders will need to provide detailed product specifications, certificates of analysis, and potentially evidence of regulatory approval. The evaluation will focus on product quality, reliability of supply, supplier credentials, and competitive pricing. This tender represents an opportunity for pharmaceutical manufacturers and distributors specializing in immunoglobulins.

Data provenance

This notice is sourced from Belgium e-Procurement and was originally published on August 11, 2026. Last refreshed today. Original language: French. BidsFactory mirrors official procurement notices and links back to the source for full legal text.

About MercurHosp ASBL

MercurHosp ASBL has issued 33 procurement notices on BidsFactory, including 6 currently open and 2 awarded contracts. Activity concentrates in Health & Medical, General Supplies & Services, and Architecture & Engineering Services. All notices are published for Belgium. Notices are distributed via Belgium e-Procurement and TED - Tenders Electronic Daily (EU). Most recent publication: August 11, 2026.

Frequently asked questions about this tender

How can I submit a bid?

Visit Belgium e-Procurement to access the full notice, required documents, and submission instructions provided by the contracting authority.

When does this tender close?

The submission deadline is September 17, 2026. You have 37 days left to prepare and submit your proposal to the contracting authority.

Who is the contracting authority?

This notice was issued by MercurHosp ASBL in Belgium. The authority is responsible for evaluating bids, awarding the contract, and managing performance.

What type of contract is this?

This is a Supplies contract in the Health & Medical sector. The classification helps bidders match the opportunity to their qualifications and registered scope of supply.

Where will the contract be performed?

The contract is for delivery in Belgium. Foreign bidders should review local registration, taxation, and any in-country presence requirements before submitting.